Generic Medicine Info
Severe renal or hepatic failure; blood disorders; hypersensitivity; acute porphyria; lupus erythematosus. Pregnancy and lactation. Infants 1-2 mth.
Special Precautions
Adequate fluid intake to reduce risk of crystalluria; discontinue if rash occurs; renal or hepatic failure or with blood disorders; asthma or history of allergy; elderly; slow acetylators are at higher risk of adverse reactions. CBC and urinalyses should be monitored regularly during prolonged treatment. G6PD deficient patients.
Adverse Reactions
GI disturbances; hypersensitivity reactions; skin and nephrotoxic reactions; SLE; blood disorders; serum sickness-like syndrome; hepatotoxicity; myocarditis; pulmonary eosinophilia and fibrosing alveolitis, vasculitis; hypoglycaemia, hypothyroidism, neurological reactions, jaundice and kernicterus in premature neonates, pseudomembranous colitis.
Drug Interactions
Potentiates effects of oral anticoagulants, methotrexate, phenytoin, NSAIDs; hypoglycaemic effect when given with sulfonylureas; reduces cyclosporin concentration; failure of hormonal contraceptives; antagonised by PABA and its derivatives. Compounds which render the urine acidic.
Lab Interference
Interference with tests for urea, creatinine, urinary glucose, urobilinogen.
Description: Succinylsulfathiazole, a sulfonamide, is an antibiotic which has activity against organisms in the GI tract.
Absorption: Poorly absorbed.
MIMS Class
Disclaimer: This information is independently developed by MIMS based on Succinylsulfathiazole from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2022 MIMS. All rights reserved. Powered by
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in